Non-invasive ventilation in amyotrophic lateral sclerosis
- PMID: 31258624
- PMCID: PMC6589990
- DOI: 10.1177/1756286419857040
Non-invasive ventilation in amyotrophic lateral sclerosis
Abstract
Non-invasive ventilation (NIV) has become an important cornerstone of symptomatic treatment in amyotrophic lateral sclerosis (ALS), improving survival and quality of life. In this review, we summarize the most important recent developments and insights, including evidence of efficacy, indication criteria and time of initiation, ventilation parameters and adaptation strategies, treatment of complicating factors, transition from NIV to invasive ventilation, termination of NIV and end-of-life management. Recent publications have questioned former conventions and guideline recommendations, especially with regard to timing and prognostic factors; therefore, a fresh look and re-evaluation of current evidence is needed.
Keywords: amyotrophic lateral sclerosis; motor neuron diseases; non-invasive ventilation.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
References
-
- Forsgren L, Almay BG, Holmgren G, et al. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20–29. - PubMed
-
- Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006; 5: 140–147. - PubMed
-
- Radunovic A, Annane D, Rafiq MK, et al. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2017; 6: CD004427. - PubMed
-
- Hirose T, Kimura F, Tani H, et al. Clinical characteristics of long-term survival with non-invasive ventilation and factors affecting the transition to invasive ventilation in ALS. Muscle Nerve 2018; 58: 770–776. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
